Clinical Trial

Clinical, Oncological and Metabolic Effects of Pancreatic Mass Loss After Partial, Near-total and Total Pancreatectomy in Patients With Preoperative Diabetes Mellitus

Study acronym: DCP-DM
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study will examine how removal of part or all of the pancreas affects blood sugar control, metabolism, and clinical outcomes over time. The study will include adults with diabetes before surgery who undergo pancreatic surgery as part of routine clinical care at Fondazione Policlinico Universitario A. Gemelli IRCCS. Researchers will study whether glycemic control worsens after surgery and whether this risk changes according to the type of pancreatic resection. The study will also examine changes in glucose metabolism, and cancer-related outcomes. Information from routine clinical care, metabolic tests, imaging, and pancreatic tissue samples collected during surgery may be used for research analyses.
Trial Details
NCT Number NCT07607912
Lead Sponsor Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Collaborators: European Foundation for the Study of Diabetes
Conditions Diabetes Mellitus Type 2, Pancreatectomy, Pancreatic Neoplasms
Enrollment 408 participants
Start Date 2026-05
Primary Completion 2037-05 (estimated)
Study Completion 2041-05 (estimated)
Updated on ClinicalTrials.gov 2026-05-26